Cited by — A Phase I, Single Ascending Dose Study of Cimaglermin Alfa (Neuregulin 1β3) in Patients With Systolic Dysfunction and Heart Failure | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite A Phase I, Single Ascending Dose Study of Cimaglermin Alfa (Neuregulin 1β3) in Patients With Systolic Dysfunction and Heart Failure.
No admitted local citation edges point to this work yet.
